Medical Research Council - London Institute of Medical Sciences

Now in our 10th year of bringing you beautiful imagery from biomedical science every day

Halting Diabetes Destruction

A mitochondrial protein called MOTS-c is implicated in type 1 diabetes

12 September 2021

Halting Diabetes Destruction

Type 1 diabetes occurs when the body’s immune system attacks its own pancreatic islet cells – specifically the beta cells, which produce insulin. The pancreatic islets of mice with a version of type 1 diabetes are shown above. On the left, the animal’s T cells can be seen crowding into the islet to destroy the beta cells, while on the right far fewer T cells are present. That’s because the animal on the right had been receiving daily injections of a recently discovered mitochondrial protein called MOTS-c, which possesses T cell regulatory activity. Animals treated with MOTS-c had preserved insulin production and improved blood glucose levels compared with controls. They also had significantly delayed onset of diabetes or no diabetes at all. The discovery that patients with type 1 diabetes have unusually low levels of MOTS-c suggests novel treatments aimed at boosting the protein’s activity may be of clinical benefit.

Written by Ruth Williams

Search The Archive

Submit An Image

What is BPoD?

BPoD stands for Biomedical Picture of the Day. Managed by the MRC London Institute of Medical Sciences the website aims to engage everyone, young and old, in the wonders of biomedicine. Images are kindly provided for inclusion on this website through the generosity of scientists across the globe.

Read More

BPoD is also available in Catalan at www.bpod.cat with translations by the University of Valencia.